Michael M. Goldberg
2016
In 2016, Michael M. Goldberg earned a total compensation of $194.2K as President and Chief Executive Officer at Navidea Biopharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $110,685 |
|---|---|
| Salary | $83,077 |
| Other | $436 |
| Total | $194,198 |
Goldberg received $110.7K in non-equity incentive plan, accounting for 57% of the total pay in 2016.
Goldberg also received $83.1K in salary and $436 in other compensation.
Rankings
In 2016, Michael M. Goldberg's compensation ranked 13,438th out of 14,075 executives tracked by ExecPay. In other words, Goldberg earned more than 4.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,438 out of 14,075 | 5th |
Division Manufacturing | 5,251 out of 5,489 | 4th |
Major group Chemicals And Allied Products | 1,836 out of 1,895 | 3rd |
Industry group Drugs | 1,489 out of 1,538 | 3rd |
Industry In Vitro and In Vivo Diagnostic Substances | 62 out of 65 | 5th |
Source: SEC filing on May 24, 2017.
Goldberg's colleagues
We found six more compensation records of executives who worked with Michael M. Goldberg at Navidea Biopharmaceuticals in 2016.
2016
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2016
Jed Latkin
Navidea Biopharmaceuticals
Chief Financial Officer
2016
Thomas Klima
Navidea Biopharmaceuticals
Senior Vice President and Chief Commercial Officer
2016
William Regan
Navidea Biopharmaceuticals
Senior Vice President and Chief Compliance Officer
2016
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2016
Ricardo Gonzalez
Navidea Biopharmaceuticals